No connection

Search Results

HITI vs MENS

HITI
High Tide Inc.
BEARISH
Price
$2.33
Market Cap
$204.8M
Sector
Healthcare
AI Confidence
80%
MENS
Jyong Biotech Ltd.
BEARISH
Price
$2.79
Market Cap
$212.1M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
HITI
--
MENS
--
Forward P/E
HITI
16.47
MENS
--
P/B Ratio
HITI
3.23
MENS
-8.91
P/S Ratio
HITI
0.33
MENS
--
EV/EBITDA
HITI
10.1
MENS
-121.13

Profitability

Gross Margin
HITI
25.8%
MENS
0.0%
Operating Margin
HITI
2.32%
MENS
0.0%
Profit Margin
HITI
-7.42%
MENS
0.0%
ROE
HITI
-39.72%
MENS
--
ROA
HITI
3.87%
MENS
-5.44%

Growth

Revenue Growth
HITI
25.2%
MENS
--
Earnings Growth
HITI
--
MENS
--

Financial Health

Debt/Equity
HITI
1.1
MENS
--
Current Ratio
HITI
1.43
MENS
0.62
Quick Ratio
HITI
0.49
MENS
0.62

Dividends

Dividend Yield
HITI
--
MENS
--
Payout Ratio
HITI
0.0%
MENS
0.0%

AI Verdict

HITI BEARISH

HITI exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and operational inefficiency. While the company shows strong top-line revenue growth of 25.20% and analysts maintain a 'strong_buy' rating with a target of $5.67, these are contradicted by a 0/100 technical trend and a negative profit margin of -7.42%. The disconnect between analyst optimism and the deterministic health scores suggests a high-risk speculative play rather than a value investment. The company's inability to convert revenue growth into consistent net income remains the primary concern.

Strengths
Strong YoY revenue growth of 25.20%
Positive operating margin of 2.32% suggesting core business viability
Very low Price/Sales ratio (0.33) indicating potential undervaluation of assets
Risks
Critical financial health (Piotroski F-Score 2/9)
Severe technical bearishness (Technical Trend 0/100)
Poor liquidity for immediate obligations (Quick Ratio 0.49)
MENS BEARISH

MENS exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a critical lack of fundamental value. The company reports a negative Price-to-Book ratio of -8.91, indicating negative shareholders' equity, and a Current Ratio of 0.62, signaling an immediate liquidity crisis. With zero reported revenue and a catastrophic 95% price decline over the last six months, the stock appears to be in a speculative death spiral. Recent short-term gains are likely volatility-driven 'dead cat bounces' rather than a fundamental recovery.

Strengths
Recent short-term price recovery (+40.9% in 1 month)
Small market cap allows for high volatility spikes
Operates in the high-growth Healthcare/Biotech sector
Risks
Negative book value indicating insolvency risk
Severe liquidity shortage (Current Ratio 0.62)
Complete absence of revenue and profit margins

Compare Another Pair

HITI vs MENS: Head-to-Head Comparison

This page compares High Tide Inc. (HITI) and Jyong Biotech Ltd. (MENS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile